V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159774 | 20061429 | 1.72 | 90 | Neo-adjuvant (N) | 2018-03-14 | 2018-04-01 | ECX | 02 | N | ECX | 101746349 |
| 20159776 | 20061430 | 1.72 | 55.2 | Palliative (P) | 2018-05-29 | 2018-06-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101133508 |
| 20159778 | 20061431 | 1.66 | 75.6 | Adjuvant (A) | 2018-01-08 | 2018-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100837371 |
| 20159779 | 20061432 | 1.57 | 67.7 | Neo-adjuvant (N) | 2019-02-13 | 2019-03-10 | ECX | 02 | N | ECX | 100026100 |
| 20159783 | 20061433 | 1.74 | 65.9 | Neo-adjuvant (N) | 2017-09-15 | 2017-09-20 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100573422 |
| 20159785 | 20061434 | 1.76 | 64.9 | Neo-adjuvant (N) | 2019-06-09 | 2019-07-07 | ECX | N | N | ECX | 100057369 |
| 20159786 | 20061435 | 1.73 | 52 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101340691 |
| 20159789 | 20061436 | 1.8 | 65.2 | Neo-adjuvant (N) | 2017-01-12 | 2017-01-18 | ECX | N | N | ECX | 100592684 |
| 20159791 | 20061437 | 1.6 | 86.6 | Palliative (P) | 2019-05-28 | 2019-06-14 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101550539 |
| 20159795 | 20061438 | 1.59 | 61.3 | Adjuvant (A) | 2019-12-22 | 2019-12-25 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101514601 |
| 20159796 | 20061439 | 1.68 | 65 | Curative (C) | 2018-11-10 | 2018-11-20 | ECX | N | N | ECX | 101121763 |
| 20159797 | 20061440 | 1.66 | 114 | Neo-adjuvant (N) | 2016-11-15 | 2016-11-20 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100862235 |
| 20159798 | 20061441 | 1.63 | 66.6 | Neo-adjuvant (N) | 2017-06-09 | 2017-07-14 | ECX | 02 | N | ECX | 100374342 |
| 20159799 | 20061442 | 1.74 | 95.1 | Palliative (P) | 2016-12-06 | 2016-12-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100736440 |
| 20159800 | 20061443 | 1.64 | 55.8 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-23 | ECX | N | N | ECX | 100624202 |
| 20159801 | 20061444 | null | null | Curative (C) | 2017-06-30 | 2017-07-16 | ECX | N | N | ECX | 100913221 |
| 20159802 | 20061445 | 1.6 | 53.3 | Neo-adjuvant (N) | 2017-09-12 | 2017-09-25 | ECX | N | N | ECX | 101062301 |
| 20159803 | 20061446 | 1.76 | 91.8 | Adjuvant (A) | 2018-12-20 | 2019-01-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101818231 |
| 20159805 | 20061447 | 1.57 | 72.1 | Adjuvant (A) | 2018-09-13 | 2018-09-28 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 101462551 |
| 20159806 | 20061448 | 1.62 | 56 | Neo-adjuvant (N) | 2018-01-04 | 2018-01-22 | ECX | N | N | ECX | 100460225 |
| 20159807 | 20061449 | 1.78 | 56.5 | Palliative (P) | 2017-07-30 | 2017-08-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101668825 |
| 20159808 | 20061450 | 1.6 | 46.3 | Palliative (P) | 2020-02-28 | 2020-02-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100084312 |
| 20159809 | 20061451 | 1.81 | 57.7 | null | 2018-01-29 | 2018-02-01 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100199158 |
| 20159810 | 20061452 | null | null | Palliative (P) | 2018-01-13 | 2018-01-31 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100245900 |
| 20159811 | 20061453 | 1.65 | 48 | Palliative (P) | 2018-03-19 | 2018-03-30 | ECX | N | N | ECX | 100963156 |
| 20159812 | 20061454 | 1.72 | 81.9 | Neo-adjuvant (N) | 2017-09-13 | 2017-09-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100688759 |
| 20159814 | 20061455 | 1.64 | 74.05 | Neo-adjuvant (N) | 2017-04-04 | 2017-04-26 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101391897 |
| 20159815 | 20061456 | 1.65 | 73.3 | Palliative (P) | 2016-12-08 | 2016-12-26 | ECX | 02 | N | ECX | 100869365 |
| 20159816 | 20061457 | 1.6 | 59.2 | Disease modification (D) | 2019-09-04 | 2019-09-11 | ECX | null | N | ECX | 101558699 |
| 20159818 | 20061458 | 1.57 | 63.2 | Adjuvant (A) | 2019-08-15 | 2019-08-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101861050 |
| 20159821 | 20061459 | 1.78 | 45 | Neo-adjuvant (N) | 2016-11-20 | 2016-12-05 | ECX | N | N | ECX | 101236088 |
| 20159822 | 20061460 | 1.61 | 54.2 | Adjuvant (A) | 2018-06-07 | 2018-06-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100359345 |
| 20159825 | 20061461 | 1.79 | 48 | Neo-adjuvant (N) | 2016-05-01 | 2016-05-10 | ECX | 02 | N | ECX | 101119054 |
| 20159826 | 20061462 | 1.66 | 67 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-09 | ECX | N | N | ECX | 101731305 |
| 20159827 | 20061463 | 1.78 | 100.7 | Palliative (P) | 2016-09-15 | 2016-10-02 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100554205 |
| 20159828 | 20061464 | 1.78 | 100.8 | Palliative (P) | 2017-06-07 | 2017-06-08 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101185540 |
| 20159829 | 20061465 | 1.58 | 79.8 | Curative (C) | 2016-08-10 | 2016-08-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101475174 |
| 20159831 | 20061466 | 1.66 | 95 | Curative (C) | 2019-07-11 | 2019-07-25 | ECX | N | N | ECX | 101436205 |
| 20159833 | 20061467 | 1.74 | 68 | Adjuvant (A) | 2016-06-22 | 2016-06-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100958646 |
| 20159835 | 20061468 | 1.74 | 71.3 | Curative (C) | 2019-07-27 | 2019-08-01 | ECX | N | N | ECX | 100489344 |
| 20159836 | 20061469 | 1.78 | 56.8 | Adjuvant (A) | 2017-04-06 | 2017-04-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101695913 |
| 20159838 | 20061470 | 1.71 | 52.4 | Palliative (P) | 2018-07-06 | 2018-07-20 | ECX | N | N | ECX | 100879425 |
| 20159839 | 20061471 | 1.7 | 58 | Palliative (P) | 2019-06-02 | 2019-06-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100223237 |
| 20159840 | 20061472 | 1.75 | 90.9 | Adjuvant (A) | 2019-09-29 | 2019-09-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101691931 |
| 20159843 | 20061473 | 1.75 | 83.3 | Adjuvant (A) | 2019-05-25 | 2019-06-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101009909 |
| 20159844 | 20061474 | 1.62 | 102 | Curative (C) | 2018-04-10 | 2018-04-26 | ECX | N | N | ECX | 101396368 |
| 20159845 | 20061475 | 1.75 | null | Palliative (P) | 2019-08-18 | 2019-08-19 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100755494 |
| 20159846 | 20061476 | 1.56 | 54.6 | Palliative (P) | 2019-11-17 | 2019-11-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101809266 |
| 20159847 | 20061477 | 1.66 | 75 | Palliative (P) | 2017-01-10 | 2017-01-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100493068 |
| 20159848 | 20061478 | 1.72 | 62.4 | Palliative (P) | 2017-09-13 | 2017-09-18 | Gemcitabine + Capecitabine | N | N | ECX | 101209907 |